NCT06965712 Use of Point-of-Care Ultrasound (POCUS) to Reduce Hospital Length of Stay in Patients With Heart Failure ( POCUSHF )
| NCT ID | NCT06965712 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Florida International University |
| Condition | Heart Failure |
| Study Type | INTERVENTIONAL |
| Enrollment | 66 participants |
| Start Date | 2025-11-24 |
| Primary Completion | 2026-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 66 participants in total. It began in 2025-11-24 with a primary completion date of 2026-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will evaluate whether using bedside ultrasound (also called Point-of-Care Ultrasound or POCUS) can help improve the care of hospitalized patients with decompensated heart failure. Patients will be randomly assigned to two groups: one group will receive ultrasound-guided assessments, and the other group will receive standard clinical evaluations. Researchers will compare the hospital length of stay between the two groups. Ultrasound is a non-invasive, safe, and painless imaging tool. The goal of the study is to find out if ultrasound guidance can lead to shorter hospitalizations and better care for patients with heart failure.
Eligibility Criteria
Inclusion Criteria: Adults aged 18 years and older. Hospitalized with a primary diagnosis of decompensated heart failure (left, right, or biventricular). Evidence of volume overload or congestion based on Framingham criteria, clinical examination, elevated proBNP (\>1000 pg/mL), or chest X-ray showing pulmonary edema. Ability to undergo bedside ultrasound evaluation (POCUS) as clinically feasible. Able to provide informed consent. Exclusion Criteria: Age under 18 years. Pregnant or breastfeeding women. Terminal illness with life expectancy \< 30 days. Inability to obtain ultrasound images due to body habitus or other technical reasons. Enrollment in another interventional clinical trial that could interfere with the outcomes of this study.
Contact & Investigator
GUILLERMO IZQUIERDO PRETEL, MD
PRINCIPAL INVESTIGATOR
Florida International University
Frequently Asked Questions
Who can join the NCT06965712 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06965712 currently recruiting?
Yes, NCT06965712 is actively recruiting participants. Contact the research team at gizquier@fiu.edu for enrollment information.
Where is the NCT06965712 trial being conducted?
This trial is being conducted at Miami, United States.
Who is sponsoring the NCT06965712 clinical trial?
NCT06965712 is sponsored by Florida International University. The principal investigator is GUILLERMO IZQUIERDO PRETEL, MD at Florida International University. The trial plans to enroll 66 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.